Cognitive Behavioral Therapy for Insomnia and Nightmares
(RESTED Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether cognitive behavioral therapy (CBT) can improve sleep issues and PTSD symptoms in individuals who have recently experienced violence. The study compares two groups: one receiving CBT focused on insomnia and nightmares, and another receiving general sleep education enhanced with nightmare education. Participants will attend six weekly telehealth sessions and report changes in their symptoms. Individuals treated at Henry Ford Hospital after a violent incident in the last 72 hours, who are not currently in other CBT treatments, may find this trial suitable. As an unphased trial, this study offers a unique opportunity to contribute to understanding how CBT can benefit those with recent trauma.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this therapy is safe for treating posttraumatic sleep disturbance?
Research has shown that cognitive behavioral therapy for insomnia (CBT-I) safely treats sleep problems. Studies have found it to be a non-drug treatment that improves sleep without the side effects often associated with sleeping pills. People generally tolerate CBT-I well without major issues.
One study highlighted that CBT-I is particularly beneficial for those with nightmares, suggesting it can effectively reduce symptoms without causing harm. Health care professionals recommend this therapy to improve sleep and potentially lower the risk of suicidal thoughts.
Overall, CBT-I is considered a safe and effective treatment for insomnia and nightmares, making it a good choice for those seeking to improve their sleep.12345Why are researchers excited about this trial?
Researchers are excited about Cognitive Behavioral Therapy (CBT) for Insomnia and Nightmares because it directly targets and modifies unhelpful thoughts and behaviors, setting it apart from standard treatments like medication. Unlike typical sleep medications that often focus on symptoms and may have side effects, CBT addresses the root causes of sleep issues, offering a long-term solution. Additionally, the therapy empowers individuals with skills and strategies to manage insomnia and nightmares, promoting lasting improvements in sleep quality.
What evidence suggests that this trial's treatments could be effective for posttraumatic sleep disturbance?
Research has shown that cognitive behavioral therapy for insomnia (CBT-I), which participants in this trial may receive, helps improve sleep and reduces insomnia symptoms. Most individuals who try CBT-I report better sleep. In this trial, some participants will receive CBT-I combined with special therapy for nightmares (CBT-I&N), which can decrease the frequency of nightmares and enhance overall sleep quality. Studies suggest that CBT-I&N might also help reduce post-traumatic stress symptoms. These therapies are available through telehealth, providing easy and convenient access.36789
Are You a Good Fit for This Trial?
This trial is for acute trauma patients who have experienced interpersonal violence and are now dealing with sleep disturbances like insomnia or nightmares, possibly related to PTSD. Participants should be comfortable using telehealth services.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive cognitive behavioral therapy for insomnia and nightmares via telehealth
Follow-up
Participants are monitored for changes in insomnia and PTSD symptoms after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy for Insomnia and Nightmares
- Sleep Education enhanced with Nightmare Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry Ford Health System
Lead Sponsor
American Academy of Sleep Medicine
Collaborator